Net earnings increased 26% year-over-year to $128.2 million.
Operating margin increased 150 basis points to 17.5% due to favorable absorption.
Repurchased approximately 22,000 shares for $14 million during the quarter.
Ongoing share-based compensation and restricted stock issuance.
The Q1 2026 filing paints a picture of a company in a high-growth phase, successfully capturing the tailwinds of increased defense spending and nuclear energy demand. The operational metrics are undeniably strong, with double-digit growth in sales and a significant jump in earnings per share. The expansion of the backlog to $4.3 billion provides a critical safety net and a predictable revenue stream for the next three years. However, the disconnect between accounting earnings and cash flow remains the central point of tension for investors. The rise in working capital needs and the continued negative operating cash flow suggest that the cost of supporting this growth is substantial. The company is essentially borrowing from its balance sheet and utilizing credit facilities to fund the gap between production and collection. Ultimately, the investment thesis hinges on whether the current operational momentum can outpace the inherent risks of high debt and long-cycle government contracts. If Curtiss-Wright can stabilize its cash conversion cycle while maintaining its margin expansion, it remains a powerful compounder. Conversely, any disruption in the U.S. Navy's shipbuilding pipeline or a failure in the commercial nuclear prototype stage could rapidly erode the current valuation premium.